For research use only. Not for therapeutic Use.
VEGFR2-IN-7 (Cat No.: I040147) is a potent small-molecule inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR2), a key regulator of angiogenesis. By inhibiting VEGFR2, it suppresses tumor blood vessel formation, reducing tumor growth and metastasis. VEGFR2-IN-7 has shown promise in preclinical models of cancer, particularly in solid tumors, and could provide a valuable therapeutic strategy in cancer treatment, particularly for tumors resistant to conventional therapies. Its selective action offers a potential for reduced side effects.
| CAS Number | 174258-31-2 |
| Synonyms | [3-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methanol |
| Molecular Formula | C18H17NO3 |
| Purity | ≥95% |
| InChI | InChI=1S/C18H17NO3/c1-13-17(12-21-16-9-5-6-14(10-16)11-20)19-18(22-13)15-7-3-2-4-8-15/h2-10,20H,11-12H2,1H3 |
| InChIKey | UPVJJOGZAKVERR-UHFFFAOYSA-N |
| SMILES | CC1=C(N=C(O1)C2=CC=CC=C2)COC3=CC=CC(=C3)CO |
